Actually both patients have been cured and released and they really don’t know if the experimental drug ZMapp helped or not. Both were the first recipients of the drug.
This is really good news and is hope for those in Africa with work over there. Both pose no public health threat as the virus is gone. It will be interesting to see if both return or stay in the US after this experience.
It was the right decision to bring both patients back to the US. Room sensor robots with cleaning hospital rooms will play a big part to keep the virus off the walls, or anywhere else it could live. Two of the cleaning robots are headed on their way to Africa. BD
The two American Ebola patients, medical missionaries Nancy Writebol and Dr. Kent Brantly, have walked out of Emory University Hospital in Atlanta infection-free.
They were the first human beings to receive an experimental drug called ZMapp. But they are not the first people to have recovered from Ebola, and good hospital care is likely more responsible for their recovery than any mysterious “serum," as the charities they work for termed it.
Dr. Jesse Goodman, a former top Food and Drug Administration official who is now at Georgetown University, notes that most drugs fail during experimental trials. “Furthermore, using unproven therapies during emergencies, without adequately evaluating their effectiveness, may result in misleading, even harmful conclusions," he writes in this week’s issue of the New England Journal of Medicine.